Koyama S, Etkins J, Jun J, Miller M, So G, Gisch D
Int J Mol Sci. 2025; 26(2).
PMID: 39859413
PMC: 11765766.
DOI: 10.3390/ijms26020699.
Hwang S, Song J, Choi J, Jung Y, Park C, Kim Y
Biomolecules. 2024; 14(9).
PMID: 39334923
PMC: 11429562.
DOI: 10.3390/biom14091157.
Eto K, Cheung D, Nabekura J
Adv Exp Med Biol. 2024; 1461:127-137.
PMID: 39289278
DOI: 10.1007/978-981-97-4584-5_9.
Anam A, Liu C, Tong L, Liu Y
J Ocul Pharmacol Ther. 2024; 40(5):281-292.
PMID: 38648544
PMC: 11296151.
DOI: 10.1089/jop.2023.0155.
Almousa A, Subash-Babu P, Alanazi I, Alshatwi A, Alkhalaf H, Bahattab E
Molecules. 2024; 29(7).
PMID: 38611847
PMC: 11013118.
DOI: 10.3390/molecules29071568.
Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options.
Mallick-Searle T, Adler J
J Pain Res. 2024; 17:1005-1028.
PMID: 38505500
PMC: 10949339.
DOI: 10.2147/JPR.S442595.
Unveiling the mechanisms of neuropathic pain suppression: perineural resiniferatoxin targets Trpv1 and beyond.
Shehab S, Javed H, Johnson A, Tariq S, Kumar C, Emerald B
Front Neuroanat. 2023; 17:1306180.
PMID: 38099210
PMC: 10720729.
DOI: 10.3389/fnana.2023.1306180.
Transient receptor potential vanilloid 1: A potential therapeutic target for the treatment of osteoarthritis and rheumatoid arthritis.
Liao Z, Umar M, Huang X, Qin L, Xiao G, Chen Y
Cell Prolif. 2023; 57(3):e13569.
PMID: 37994506
PMC: 10905355.
DOI: 10.1111/cpr.13569.
Emerging Advances in Nanocarriers Approaches in the Effective Therapy of Pain Related Disorders: Recent Evidence and Futuristic Needs.
Chaurawal N, Kataria M, Kumar M, Mishra N, Goni V, Raza K
AAPS PharmSciTech. 2023; 24(5):111.
PMID: 37118029
DOI: 10.1208/s12249-023-02567-y.
Cost-Effective Pipeline for a Rational Design and Selection of Capsaicin Analogues Targeting TRPV1 Channels.
Bustos D, Galarza C, Ordonez W, Brauchi S, Benso B
ACS Omega. 2023; 8(13):11736-11749.
PMID: 37033853
PMC: 10077575.
DOI: 10.1021/acsomega.2c05672.
Peripheral Nerve Denervation in Streptozotocin-Induced Diabetic Rats Is Reduced by Cilostazol.
Tseng K, Wang H, Wang Y, Su M, Cheng K, Cheng K
Medicina (Kaunas). 2023; 59(3).
PMID: 36984553
PMC: 10057442.
DOI: 10.3390/medicina59030553.
Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) for Postoperative Pain After Photorefractive Keratectomy.
Thompson V, Moshirfar M, Clinch T, Scoper S, Linn S, McIntosh A
Transl Vis Sci Technol. 2023; 12(3):7.
PMID: 36917119
PMC: 10020951.
DOI: 10.1167/tvst.12.3.7.
In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity.
Andrei C, Mihai D, Zanfirescu A, Nitulescu G, Negres S
Pharmaceutics. 2022; 14(12).
PMID: 36559057
PMC: 9781017.
DOI: 10.3390/pharmaceutics14122563.
Highly Efficient Real-Time TRPV1 Screening Methodology for Effective Drug Candidates.
Lim S, Seo S, Jo S, Kim K, Kim L, Kwon O
ACS Omega. 2022; 7(41):36441-36447.
PMID: 36278091
PMC: 9583638.
DOI: 10.1021/acsomega.2c04202.
TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids.
Louis-Gray K, Tupal S, Premkumar L
Int J Mol Sci. 2022; 23(17).
PMID: 36077412
PMC: 9456209.
DOI: 10.3390/ijms231710016.
Scorpion Venom peptide, AGAP inhibits TRPV1 and potentiates the analgesic effect of lidocaine.
Kampo S, Cui Y, Yu J, Anabah T, Falagan A, Bayor M
Heliyon. 2022; 7(12):e08560.
PMID: 35005265
PMC: 8715296.
DOI: 10.1016/j.heliyon.2021.e08560.
Nanotechnology for Pain Management: Current and Future Therapeutic Interventions.
Bhansali D, Teng S, Lee C, Schmidt B, Bunnett N, Leong K
Nano Today. 2021; 39.
PMID: 34899962
PMC: 8654201.
DOI: 10.1016/j.nantod.2021.101223.
New 2-(4-(4-bromophenylsulfonyl)phenyl)-4-arylidene-oxazol-5(4H)-ones: analgesic activity and histopathological assessment.
Barbuceanu F, Rosca E, Apostol T, Seremet O, Draghici C, Mihai D
Rom J Morphol Embryol. 2021; 61(2):493-502.
PMID: 33544801
PMC: 7864298.
DOI: 10.47162/RJME.61.2.19.
Inhibition of the Soluble Epoxide Hydrolase as an Analgesic Strategy: A Review of Preclinical Evidence.
Wang Y, Wagner K, Morisseau C, Hammock B
J Pain Res. 2021; 14:61-72.
PMID: 33488116
PMC: 7814236.
DOI: 10.2147/JPR.S241893.
Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain.
Huygen F, Kern K, Perez C
J Pain Res. 2020; 13:2585-2597.
PMID: 33116801
PMC: 7569173.
DOI: 10.2147/JPR.S263054.